Data / Drug companies / Sympathomimetic Amine Anorectic
Sympathomimetic Amine Anorectic drugs: 8 drugs from 36 companies in the FDA NDC directory
Sympathomimetic Amine Anorectic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 187 products in this class from 36 companies, covering 8 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 25, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 36Companies
- 187Products
- 8Drugs by generic name
Drugs in the Sympathomimetic Amine Anorectic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Phentermine hydrochloride | 120 | 26 |
| Phendimetrazine tartrate | 20 | 13 |
| Diethylpropion hydrochloride | 22 | 12 |
| Benzphetamine hydrochloride | 6 | 6 |
| Phentermine and topiramate | 12 | 3 |
| Phentermine and topiramate extended-release | 4 | 1 |
| Phentermine hcl c-iv | 2 | 1 |
| Diethylpropion hydrochloride er | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 21 | tablet; capsule | Generic drugs (ANDA) | February 15, 2024 |
| Bryant Ranch Prepack | 17 | capsule; tablet | Generic drugs (ANDA) | June 17, 2020 |
| A-S Medication Solutions | 13 | capsule; tablet | Generic drugs (ANDA) | January 24, 2017 |
| Calvin Scott & Co., Inc. | 13 | tablet; capsule | Generic drugs (ANDA) | February 15, 2024 |
| KVK-Tech, Inc. | 12 | tablet; capsule | Generic drugs (ANDA) | March 29, 2018 |
| NuCare Pharmaceuticals,Inc. | 11 | tablet; capsule | Generic drugs (ANDA) | January 24, 2017 |
| Bryant Ranch Prepack | 9 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 8 | tablet; capsule | Generic drugs (ANDA) | August 12, 2013 |
| PD-Rx Pharmaceuticals, Inc. | 7 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Direct_Rx | 6 | tablet; capsule | Generic drugs (ANDA) | March 13, 2026 |
| Martek Pharmacal Co. | 6 | tablet; capsule | Generic drugs (ANDA) | June 1, 2024 |
| Proficient Rx LP | 5 | tablet; capsule | Generic drugs (ANDA) | August 7, 2012 |
| Dr. Reddy's Laboratories Inc. | 4 | capsule | Generic drugs (ANDA) | June 12, 2025 |
| Prasco Laboratories | 4 | capsule, extended release | Authorized generics (NDA) | June 1, 2025 |
| Preferred Pharmaceuticals Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | July 28, 2021 |
| Proficient Rx LP | 4 | tablet; capsule | Generic drugs (ANDA) | January 24, 2017 |
| Sunrise Pharmaceutical, Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | January 24, 2017 |
| Teva Pharmaceuticals, Inc. | 4 | capsule, extended release | Generic drugs (ANDA) | May 7, 2025 |
| Vivus LLC | 4 | capsule, extended release | New drug applications (NDA) | September 17, 2012 |
| Asclemed USA, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | January 24, 2017 |
| Aurolife Pharma, LLC | 3 | capsule; tablet | Generic drugs (ANDA) | April 10, 2026 |
| Chartwell RX, LLC | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | August 15, 2012 |
| Precision Dose, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Elite Laboratories, Inc. | 2 | tablet | Generic drugs (ANDA) | May 1, 2014 |
| Epic Pharma, LLC | 2 | tablet, film coated; capsule | Generic drugs (ANDA) | December 16, 2015 |
| Lannett Company, Inc. | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | October 24, 2011 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | June 25, 2026 |
| Acertis Pharmaceuticals, LLC | 1 | capsule, extended release | New drug applications (NDA) | November 1, 2022 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 19, 2026 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | September 15, 2010 |
| Omnivium Pharmaceuticals LLC. | 1 | tablet, extended release | Generic drugs (ANDA) | September 19, 2025 |
| Solco Healthcare US, LLC | 1 | tablet | Generic drugs (ANDA) | January 4, 2002 |
| Sun Pharmaceutical Industries, Inc. | 1 | tablet | Generic drugs (ANDA) | August 12, 2013 |
| Tagi Pharma, Inc. | 1 | tablet | Generic drugs (ANDA) | March 8, 2011 |
| Virtus Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | July 1, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 91 | 48.7% |
| Capsule | 71 | 38% |
| Capsule, extended release | 13 | 7% |
| Tablet, extended release | 10 | 5.3% |
| Tablet, film coated | 2 | 1.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.